TrialBreast cancer research and treatment2023

A phase I/II study of preoperative letrozole, everolimus, and carotuximab in stage 2 and 3 hormone receptor-positive and Her2-negative breast cancer.

Christos Vaklavas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.